Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates
- PMID: 11773054
- PMCID: PMC3018882
- DOI: 10.1074/jbc.M110527200
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates
Abstract
Galactose-alpha1,3-galactose (alphaGal) epitopes, the synthesis of which requires the enzyme product of alpha1,3-galactosyltransferase (alpha1,3GT), are sugar chains on the cell surface of most mammalian species. Notable exceptions are higher primates including Old World monkeys, apes, and humans. The alphaGal-negative species as well as mice with deletion of the alpha1,3GT gene produce abundant anti-alphaGal antibodies. The evolutionary loss of alphaGal epitopes has been attributed to point mutations in the coding region of the gene. Because no transcripts could be found in the higher primate species with Northern blot analysis, a potential alternative explanation has been loss of upstream regulation of the gene. Here, we have demonstrated that the rhesus promoter is functional. More importantly, a variety of full-length transcripts were detected with sensitive PCR-based methods in the tissues of rhesus monkeys, orangutans, and humans. Five crucial mutations were delineated in the coding region of the human and rhesus and three in the orangutan, any one of which could be responsible for inactivation of the alpha1,3GT gene. Two of the mutations were shared by all three higher primates. These findings, which elucidate the molecular basis for the evolutionary loss of alphaGal expression, may have implications in medical research.
Figures







Similar articles
-
Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).Int J Mol Med. 2016 Jan;37(1):11-20. doi: 10.3892/ijmm.2015.2397. Epub 2015 Oct 30. Int J Mol Med. 2016. PMID: 26531137 Free PMC article. Review.
-
Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene.Transplantation. 2000 Nov 15;70(9):1275-83. doi: 10.1097/00007890-200011150-00004. Transplantation. 2000. PMID: 11087141 Free PMC article.
-
Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.J Mol Evol. 2015 Jan;80(1):1-9. doi: 10.1007/s00239-014-9652-x. Epub 2014 Oct 15. J Mol Evol. 2015. PMID: 25315716 Review.
-
Possible role of a cell surface carbohydrate in evolution of resistance to viral infections in old world primates.J Virol. 2013 Aug;87(15):8317-26. doi: 10.1128/JVI.01118-13. Epub 2013 Jun 5. J Virol. 2013. PMID: 23740988 Free PMC article.
-
Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys.Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7401-4. doi: 10.1073/pnas.88.16.7401. Proc Natl Acad Sci U S A. 1991. PMID: 1908095 Free PMC article.
Cited by
-
Pancreas and islet cell transplantation.Best Pract Res Clin Gastroenterol. 2002 Jun;16(3):457-74. doi: 10.1053/bega.2002.0318. Best Pract Res Clin Gastroenterol. 2002. PMID: 12079269 Free PMC article. Review.
-
Production of alpha 1,3-galactosyltransferase-deficient pigs.Science. 2003 Jan 17;299(5605):411-4. doi: 10.1126/science.1078942. Epub 2002 Dec 19. Science. 2003. PMID: 12493821 Free PMC article.
-
Use of genetically-engineered pig donors in islet transplantation.World J Transplant. 2015 Dec 24;5(4):243-50. doi: 10.5500/wjt.v5.i4.243. World J Transplant. 2015. PMID: 26722651 Free PMC article. Review.
-
Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).Int J Mol Med. 2016 Jan;37(1):11-20. doi: 10.3892/ijmm.2015.2397. Epub 2015 Oct 30. Int J Mol Med. 2016. PMID: 26531137 Free PMC article. Review.
-
The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity.Immunology. 2021 Apr;162(4):434-451. doi: 10.1111/imm.13297. Epub 2021 Jan 4. Immunology. 2021. PMID: 33340093 Free PMC article.
References
-
- Galili U, Shohet SB, Kobrin E, Stults CLM, Macher BA. J Biol Chem. 1988;263:17755–17762. - PubMed
-
- Cooper DKC, Koren E, Oliol R. Lancet. 1993;342:682–683. - PubMed
-
- Joziasse DH, Shaper JH, Van den Eijnden DH, Van Tunen AJ, Shaper NL. J Biol Chem. 1989;264:14290–14297. - PubMed
-
- Larsen RD, Rivera-Marrero CA, Ernst LK, Cummings RD, Lowe JB. J Biol Chem. 1990;265:7055–7061. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases